Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Macerich Company (The) Common Stock (MAC) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

Macerich Company (The) Common StockTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

Macerich Company (The) Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Macerich Company (The) Common Stock trades at $22.18 (market cap $6.39B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is the larger of the two by market cap, and Macerich Company (The) Common Stock pays the higher dividend (3.02%). Which is the better fit depends on your goals — on Pluang, investors hold Macerich Company (The) Common Stock for 0 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

MACRDY
Market Cap
$6.39B$10.78B
Volume
2,684,1512,724,343
Sector
Real EstateHealth
52-Week High
$26.51$15.38
52-Week Low
$16.20$11.38
Typical Hold Time
0 Days0 Days
Enterprise Value
$11.07B$10.68B
Dividend Yield
3.02%0.65%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MAC
100% Buy0% Sell
Avg holding period · 0 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Macerich Company (The) Common Stock

The Macerich Company is a real estate investment trust that owns, operates, and redevelops shopping centers concentrated in California, the Pacific Northwest, and other major US markets.

Read more on MAC →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →